Melvyn I Marquis
Examiner (ID: 16161)
Most Active Art Unit | 1501 |
Art Unit(s) | 1402, 1505, 1503, 1501, 1712, 2200, 1754, 1401 |
Total Applications | 2620 |
Issued Applications | 2300 |
Pending Applications | 26 |
Abandoned Applications | 294 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 17635248
[patent_doc_number] => 11345965
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-05-31
[patent_title] => Materials and methods for multiplex detection of body fluids
[patent_app_type] => utility
[patent_app_number] => 17/104273
[patent_app_country] => US
[patent_app_date] => 2020-11-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 21
[patent_no_of_words] => 15339
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 158
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17104273
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/104273 | Materials and methods for multiplex detection of body fluids | Nov 24, 2020 | Issued |
Array
(
[id] => 16728197
[patent_doc_number] => 20210095344
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-04-01
[patent_title] => CYSTIC FIBROSIS GENE MUTATIONS
[patent_app_type] => utility
[patent_app_number] => 17/063076
[patent_app_country] => US
[patent_app_date] => 2020-10-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13200
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 105
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17063076
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/063076 | CYSTIC FIBROSIS GENE MUTATIONS | Oct 4, 2020 | Abandoned |
Array
(
[id] => 17104370
[patent_doc_number] => 11124566
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-09-21
[patent_title] => Methods for reducing drug-induced liver injury
[patent_app_type] => utility
[patent_app_number] => 17/032838
[patent_app_country] => US
[patent_app_date] => 2020-09-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 19277
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 47
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17032838
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/032838 | Methods for reducing drug-induced liver injury | Sep 24, 2020 | Issued |
Array
(
[id] => 17236675
[patent_doc_number] => 11180547
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-11-23
[patent_title] => Methods for reducing drug-induced liver injury
[patent_app_type] => utility
[patent_app_number] => 17/032833
[patent_app_country] => US
[patent_app_date] => 2020-09-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 19275
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 61
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17032833
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/032833 | Methods for reducing drug-induced liver injury | Sep 24, 2020 | Issued |
Array
(
[id] => 16916419
[patent_doc_number] => 20210189511
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-06-24
[patent_title] => PNA PROBES, PROBE SETS, METHODS AND KITS PERTAINING TO THE DETECTION OF CANDIDA
[patent_app_type] => utility
[patent_app_number] => 17/029575
[patent_app_country] => US
[patent_app_date] => 2020-09-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11932
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17029575
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/029575 | PNA PROBES, PROBE SETS, METHODS AND KITS PERTAINING TO THE DETECTION OF CANDIDA | Sep 22, 2020 | Abandoned |
Array
(
[id] => 16629046
[patent_doc_number] => 20210047699
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-02-18
[patent_title] => EARLY GENETIC SCREENING TO AID IN THE SELECTION OF DOGS FOR ASSISTANCE TRAINING PROGRAMS
[patent_app_type] => utility
[patent_app_number] => 16/990468
[patent_app_country] => US
[patent_app_date] => 2020-08-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6115
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 59
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16990468
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/990468 | EARLY GENETIC SCREENING TO AID IN THE SELECTION OF DOGS FOR ASSISTANCE TRAINING PROGRAMS | Aug 10, 2020 | Pending |
Array
(
[id] => 16525636
[patent_doc_number] => 20200399716
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-12-24
[patent_title] => COMPOSITIONS AND METHODS FOR DETECTION OF BABESIA
[patent_app_type] => utility
[patent_app_number] => 16/927191
[patent_app_country] => US
[patent_app_date] => 2020-07-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15408
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16927191
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/927191 | Compositions and methods for detection of | Jul 12, 2020 | Issued |
Array
(
[id] => 18545542
[patent_doc_number] => 11718883
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-08-08
[patent_title] => Compositions and methods for detection of
[patent_app_type] => utility
[patent_app_number] => 16/927123
[patent_app_country] => US
[patent_app_date] => 2020-07-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 15398
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 211
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16927123
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/927123 | Compositions and methods for detection of | Jul 12, 2020 | Issued |
Array
(
[id] => 16399203
[patent_doc_number] => 20200340061
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-10-29
[patent_title] => PERSONALIZED PAIN MANAGEMENT AND ANESTHESIA: PREEMPTIVE RISK IDENTIFICATION AND THERAPEUTIC DECISION SUPPORT
[patent_app_type] => utility
[patent_app_number] => 16/946401
[patent_app_country] => US
[patent_app_date] => 2020-06-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 36035
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -3
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16946401
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/946401 | Personalized pain management and anesthesia: preemptive risk identification and therapeutic decision support | Jun 18, 2020 | Issued |
Array
(
[id] => 19412014
[patent_doc_number] => 12077821
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-09-03
[patent_title] => Personalized pain management and anesthesia: preemptive risk identification and therapeutic decision support
[patent_app_type] => utility
[patent_app_number] => 16/946399
[patent_app_country] => US
[patent_app_date] => 2020-06-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 28
[patent_figures_cnt] => 38
[patent_no_of_words] => 36017
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 262
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16946399
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/946399 | Personalized pain management and anesthesia: preemptive risk identification and therapeutic decision support | Jun 18, 2020 | Issued |
Array
(
[id] => 16598469
[patent_doc_number] => 20210025000
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-01-28
[patent_title] => GENETIC POLYMORPHISMS ASSOCIATED WITH LIVER FIBROSIS, METHODS OF DETECTION AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/895440
[patent_app_country] => US
[patent_app_date] => 2020-06-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 50896
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16895440
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/895440 | GENETIC POLYMORPHISMS ASSOCIATED WITH LIVER FIBROSIS, METHODS OF DETECTION AND USES THEREOF | Jun 7, 2020 | Abandoned |
Array
(
[id] => 18779344
[patent_doc_number] => 11821039
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-11-21
[patent_title] => Detecting neoplasm
[patent_app_type] => utility
[patent_app_number] => 15/930267
[patent_app_country] => US
[patent_app_date] => 2020-05-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 41580
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 77
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15930267
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/930267 | Detecting neoplasm | May 11, 2020 | Issued |
Array
(
[id] => 18233429
[patent_doc_number] => 11597978
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-03-07
[patent_title] => Personalized pain management and anesthesia: preemptive risk identification and therapeutic decision support
[patent_app_type] => utility
[patent_app_number] => 16/850537
[patent_app_country] => US
[patent_app_date] => 2020-04-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 28
[patent_figures_cnt] => 38
[patent_no_of_words] => 36003
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 163
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16850537
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/850537 | Personalized pain management and anesthesia: preemptive risk identification and therapeutic decision support | Apr 15, 2020 | Issued |
Array
(
[id] => 18117771
[patent_doc_number] => 11549153
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-01-10
[patent_title] => Methods of detecting and typing pathogenic strains of
[patent_app_type] => utility
[patent_app_number] => 16/832116
[patent_app_country] => US
[patent_app_date] => 2020-03-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 28
[patent_figures_cnt] => 35
[patent_no_of_words] => 14117
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 568
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16832116
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/832116 | Methods of detecting and typing pathogenic strains of | Mar 26, 2020 | Issued |
Array
(
[id] => 16284055
[patent_doc_number] => 20200277657
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-09-03
[patent_title] => GENETIC MARKERS FOR DIAGNOSIS OF TUBERCULOSIS CAUSED BY MYCOBACTERIUM TUBERCULOSIS
[patent_app_type] => utility
[patent_app_number] => 16/806577
[patent_app_country] => US
[patent_app_date] => 2020-03-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3002
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -3
[patent_words_short_claim] => 107
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16806577
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/806577 | GENETIC MARKERS FOR DIAGNOSIS OF TUBERCULOSIS CAUSED BY MYCOBACTERIUM TUBERCULOSIS | Mar 1, 2020 | Abandoned |
Array
(
[id] => 16269207
[patent_doc_number] => 20200270694
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-08-27
[patent_title] => MARKER FOR PRENATAL DIAGNOSIS AND MONITORING
[patent_app_type] => utility
[patent_app_number] => 16/806820
[patent_app_country] => US
[patent_app_date] => 2020-03-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10795
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16806820
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/806820 | Marker for prenatal diagnosis and monitoring | Mar 1, 2020 | Issued |
Array
(
[id] => 18216735
[patent_doc_number] => 11591659
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-02-28
[patent_title] => Compositions and methods for detection of
[patent_app_type] => utility
[patent_app_number] => 16/800938
[patent_app_country] => US
[patent_app_date] => 2020-02-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 11314
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 241
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16800938
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/800938 | Compositions and methods for detection of | Feb 24, 2020 | Issued |
Array
(
[id] => 16253877
[patent_doc_number] => 20200263251
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-08-20
[patent_title] => Matrix Extracellular Phosphoglycoprotein (MEPE) Variants And Uses Thereof
[patent_app_type] => utility
[patent_app_number] => 16/784829
[patent_app_country] => US
[patent_app_date] => 2020-02-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12389
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 116
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16784829
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/784829 | Matrix Extracellular Phosphoglycoprotein (MEPE) Variants And Uses Thereof | Feb 6, 2020 | Abandoned |
Array
(
[id] => 18871465
[patent_doc_number] => 11859254
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-01-02
[patent_title] => Detecting gastric neoplasm
[patent_app_type] => utility
[patent_app_number] => 16/782841
[patent_app_country] => US
[patent_app_date] => 2020-02-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 22
[patent_no_of_words] => 27270
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 125
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16782841
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/782841 | Detecting gastric neoplasm | Feb 4, 2020 | Issued |
Array
(
[id] => 16541378
[patent_doc_number] => 20200407791
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-12-31
[patent_title] => TISSUE MOLECULAR SIGNATURES OF KIDNEY TRANSPLANT REJECTIONS
[patent_app_type] => utility
[patent_app_number] => 16/751523
[patent_app_country] => US
[patent_app_date] => 2020-01-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 33611
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 47
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16751523
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/751523 | TISSUE MOLECULAR SIGNATURES OF KIDNEY TRANSPLANT REJECTIONS | Jan 23, 2020 | Abandoned |